Cargando…
Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model
BACKGROUND: Schistosoma mansoni infection represents a major cause of morbidity and mortality in many areas of the developing world. Effective vaccines against schistosomiasis are not available and disease management relies mainly on treatment with the anthelmintic drug praziquantel. Several promisi...
Autores principales: | Mossallam, Shereen F, Amer, Eglal I, Ewaisha, Radwa E, Khalil, Amal M, Aboushleib, Hamida M, Bahey-El-Din, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389862/ https://www.ncbi.nlm.nih.gov/pubmed/25887456 http://dx.doi.org/10.1186/s12879-015-0906-z |
Ejemplares similares
-
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
por: Gonçalves de Assis, Natan Raimundo, et al.
Publicado: (2015) -
Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7
por: Reimers, Natalie, et al.
Publicado: (2015) -
The Formin-Homology Protein SmDia Interacts with the Src Kinase SmTK and the GTPase SmRho1 in the Gonads of Schistosoma mansoni
por: Quack, Thomas, et al.
Publicado: (2009) -
Sm29, but Not Sm22.6 Retains its Ability to Induce a Protective Immune Response in Mice Previously Exposed to a Schistosoma mansoni Infection
por: Alves, Clarice Carvalho, et al.
Publicado: (2015) -
Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis
por: Mossallam, Shereen F., et al.
Publicado: (2021)